Back
30
Day Range
$65.20
$73.11
52-Week Range
$65.20
$81.09
Volume
200
50D / 200D Avg
$73.11
/
$73.87
Prev Close
$73.11
Price History
Financial Trends
Peer Comparison
vs Consumer Defensive sector median (329 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 2.3 | 10.4 |
| P/B | 0.5 | 1.2 |
| ROE % | 23.8 | 12.6 |
| Net Margin % | 9.9 | 5.3 |
| Rev Growth 5Y % | 15.7 | 5.5 |
| D/E | 0.9 | 0.6 |
Key Takeaways
Revenue grew 15.73% annually over 5 years — strong growth
ROE of 23.75% indicates high profitability
Generating 1.58B in free cash flow
P/E of 2.30 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 11.40%
Cash machine — converts 101.79% of earnings into free cash flow
Growth
Revenue Growth (5Y)
15.73%
Revenue (1Y)4.33%
Earnings (1Y)6.32%
FCF Growth (3Y)16.12%
Quality
Return on Equity
23.75%
ROIC12.86%
Net Margin9.92%
Op. Margin14.00%
Safety
Debt / Equity
0.91
Current Ratio0.71
Interest Coverage8.53
Valuation
P/E Ratio
2.30
P/B Ratio0.53
EV/EBITDA4.38
Dividend Yield0.03%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 4.33% | Revenue Growth (3Y) | 10.16% |
| Earnings Growth (1Y) | 6.32% | Earnings Growth (3Y) | 19.22% |
| Revenue Growth (5Y) | 15.73% | Earnings Growth (5Y) | 4.62% |
| Profitability | |||
| Revenue (TTM) | 15.69B | Net Income (TTM) | 1.56B |
| ROE | 23.75% | ROA | 8.54% |
| Gross Margin | 40.88% | Operating Margin | 14.00% |
| Net Margin | 9.92% | Free Cash Flow (TTM) | 1.58B |
| ROIC | 12.86% | FCF Growth (3Y) | 16.12% |
| Safety | |||
| Debt / Equity | 0.91 | Current Ratio | 0.71 |
| Interest Coverage | 8.53 | Dividend Yield | 0.03% |
| Valuation | |||
| P/E Ratio | 2.30 | P/B Ratio | 0.53 |
| P/S Ratio | 0.23 | PEG Ratio | 2.02 |
| EV/EBITDA | 4.38 | Dividend Yield | 0.03% |
| Market Cap | 3.58B | Enterprise Value | 9.61B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 15.69B | 15.04B | 12.93B | 11.49B | 8.75B |
| Net Income | 1.56B | 1.46B | 1.10B | 1.49B | 1.30B |
| EPS (Diluted) | 31.35 | 29.25 | 22.01 | 30.48 | 26.86 |
| Gross Profit | 6.41B | 6.39B | 5.39B | 4.87B | 4.26B |
| Operating Income | 2.20B | 1.97B | 1.61B | 1.52B | 1.65B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 18.23B | 17.89B | 17.78B | 14.47B | 10.91B |
| Total Liabilities | 11.53B | 11.48B | 12.03B | 9.32B | 7.57B |
| Shareholders' Equity | 6.70B | 6.41B | 5.75B | 5.16B | 3.33B |
| Total Debt | 6.11B | 5.80B | 6.48B | 4.67B | 3.62B |
| Cash & Equivalents | 81.81M | 103.00M | 57.00M | 214.00M | 86.00M |
| Current Assets | 3.43B | 3.53B | 3.52B | 3.06B | 2.14B |
| Current Liabilities | 4.84B | 5.51B | 5.24B | 4.61B | 3.80B |
Strategy Scores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#319 of 658
Recent Activity
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026